PMID- 30951224 OWN - NLM STAT- MEDLINE DCOM- 20200220 LR - 20200220 IS - 1098-1101 (Electronic) IS - 0733-2459 (Linking) VI - 34 IP - 5 DP - 2019 Oct TI - Adverse events during apheresis: A 10-year experience at a tertiary academic medical center. PG - 528-536 LID - 10.1002/jca.21706 [doi] AB - BACKGROUND: Apheresis can be associated with adverse events (AEs). Available studies published on apheresis-associated AEs lack uniformity of data. Unfortunately, there is no common database in the United States (US) to report apheresis-associated AEs. We evaluated our institutional incidence of apheresis-associated AEs and compared it with published literature. STUDY DESIGN AND METHODS: We conducted a 10-year retrospective study of apheresis procedures and associated AEs at our facility, a tertiary academic medical center, from 2007 to 2016. Concurrently, a literature search was conducted on AEs associated with apheresis procedures. Twenty-eight studies including data from US and other countries' facilities were analyzed. RESULTS: The overall AE incidence was 6.9% (396/5684 procedures). Frequency of AEs associated with therapeutic plasma exchange (TPE) was higher (8.5%, P < .0001) compared to other apheresis procedures. Significant correlation between number of TPE and AEs (Spearman rho [r(s) ] = 0.7, P = .002) was encountered. Furthermore, there was a significant decrease over time of moderate and severe AEs (r(s) = -0.64, P = .04 and r(s) = -0.83, P = .003 respectively). Comparison of our institutional AEs (6.9%) to data from other countries (9.8%) and US (22.6%) indicated a significant difference (P < .0001). CONCLUSION: Overall our incidence of AEs was significantly lower than current published literature. Incidence of AEs published in other countries is significantly lower than US rates. Differences in incidence of AEs emphasize need for uniform reporting and stratification of AEs and development of a common database to report AEs. Therefore, we propose a grading rationale in order to standardize reporting of AEs. CI - (c) 2019 Wiley Periodicals, Inc. FAU - Kundrapu, Sirisha AU - Kundrapu S AUID- ORCID: 0000-0002-3779-4823 AD - Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio. AD - Department of Pathology, Division of Transfusion Medicine, Case Western Reserve University School of Medicine, Cleveland, OH. FAU - Datla, Sireesha AU - Datla S AD - Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio. FAU - Griffin, Vanessa AU - Griffin V AD - Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio. FAU - Maitta, Robert W AU - Maitta RW AUID- ORCID: 0000-0002-5424-5519 AD - Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio. AD - Department of Pathology, Division of Transfusion Medicine, Case Western Reserve University School of Medicine, Cleveland, OH. LA - eng GR - Office of Diversity and Inclusion of the University Hospitals Cleveland Medical Center/ PT - Journal Article PT - Multicenter Study DEP - 20190405 PL - United States TA - J Clin Apher JT - Journal of clinical apheresis JID - 8216305 SB - IM MH - Academic Medical Centers MH - Blood Component Removal/*adverse effects MH - Databases, Factual/*standards MH - Global Health MH - Humans MH - Incidence MH - Plasma Exchange/adverse effects MH - Retrospective Studies MH - Tertiary Care Centers MH - United States OTO - NOTNLM OT - adverse events OT - apheresis OT - complications OT - hematopoietic stem cell collection OT - red cell exchange OT - therapeutic plasma exchange EDAT- 2019/04/06 06:00 MHDA- 2020/02/23 06:00 CRDT- 2019/04/06 06:00 PHST- 2018/08/14 00:00 [received] PHST- 2019/03/21 00:00 [accepted] PHST- 2019/04/06 06:00 [pubmed] PHST- 2020/02/23 06:00 [medline] PHST- 2019/04/06 06:00 [entrez] AID - 10.1002/jca.21706 [doi] PST - ppublish SO - J Clin Apher. 2019 Oct;34(5):528-536. doi: 10.1002/jca.21706. Epub 2019 Apr 5.